Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2025
Addition of ipatasertib to dual anti-HER2 maintenance therapy in HER2-positive metastatic breast tumors with PIK3CA mutations: the phase 1b SOLTI-1507 IPATHER trial
Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa, et al.
Cancers
|
December 11, 2022
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study
Ana López González, Sonia Del Barco Berrón, Isabel Grau, et al.
International Journal of Cancer
|
January 19, 2020
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study
Clara Mayo-de-Las-Casas, Ana Velasco, Douglas Sanchez, et al.
Cell Reports
|
January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity
Vanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
Maria Vidal, Claudette Falato, Tomás Pascual, et al.
Future Oncology (London, England)
|
October 6, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of <i>PD1</i> mRNA
Aleix Prat, Luis Paz-Ares, Manel Juan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial
Eva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2020
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Eva Ciruelos, Patricia Villagrasa, Tomás Pascual, et al.
Clinical and Translational Allergy
|
January 31, 2026
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)
Isam Alobid, Sven F Seys, Joost de Kinderen, et al.
JAMA
|
January 30, 2025
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
Michail Ignatiadis, Andrew Bailey, Heather McArthur, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2025
Addition of ipatasertib to dual anti-HER2 maintenance therapy in HER2-positive metastatic breast tumors with PIK3CA mutations: the phase 1b SOLTI-1507 IPATHER trial
Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa, et al.
Cancers
|
December 11, 2022
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study
Ana López González, Sonia Del Barco Berrón, Isabel Grau, et al.
International Journal of Cancer
|
January 19, 2020
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study
Clara Mayo-de-Las-Casas, Ana Velasco, Douglas Sanchez, et al.
Cell Reports
|
January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity
Vanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
Maria Vidal, Claudette Falato, Tomás Pascual, et al.
Future Oncology (London, England)
|
October 6, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of <i>PD1</i> mRNA
Aleix Prat, Luis Paz-Ares, Manel Juan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial
Eva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2020
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Eva Ciruelos, Patricia Villagrasa, Tomás Pascual, et al.
Clinical and Translational Allergy
|
January 31, 2026
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)
Isam Alobid, Sven F Seys, Joost de Kinderen, et al.
JAMA
|
January 30, 2025
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
Michail Ignatiadis, Andrew Bailey, Heather McArthur, et al.
Page
of 5